Literature DB >> 27465156

Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.

Renée L Crisp1,2,3, Romina E Maltaneri2,4, Daniela C Vittori2,4, Liliana Solari5, Daniel Gammella5, Gabriel Schvartzman3, Eliana García6, María C Rapetti7, Hugo Donato3,7, Alcira Nesse8,9.   

Abstract

Aquaporin-1 (AQP1) is the membrane water channel responsible for changes in erythrocyte volume in response to the tonicity of the medium. As the aberrant distribution of proteins in hereditary spherocytosis (HS) generates deficiencies of proteins other than those codified by the mutated gene, we postulated that AQP1 expression might be impaired in spherocytes. AQP1 expression was evaluated through flow cytometry in 5 normal controls, 1 autoimmune hemolytic anemia, 10 HS (2 mild, 3 moderate, 2 severe, and 3 splenectomized), and 3 silent carriers. The effect of AQP1 inhibitors was evaluated through water flow-based tests: osmotic fragility and hypertonic cryohemolysis. Serum osmolality was measured in 20 normal controls and 13 HS. The effect of erythropoietin (Epo) on AQP1 expression was determined in cultures of erythroleukemia UT-7 cells, dependent on Epo to survive. Independent of erythrocyte size, HS patients showed a lower content of AQP1 in erythrocyte membranes which correlated with the severity of the disease. Accordingly, red blood cells from HS subjects were less sensitive to cryohemolysis than normal erythrocytes after inhibition of the AQP1 water channel. A lower serum osmolality in HS with respect to normal controls suggests alterations during reticulocyte remodeling. The decreased AQP1 expression could contribute to explain variable degrees of anemia in hereditary spherocytosis. The finding of AQP1 expression induced by Epo in a model of erythroid cells may be interpreted as a mechanism to restore the balance of red cell water fluxes.

Entities:  

Keywords:  Aquaporin-1; Erythropoietin; Serum osmolality; Spherocytosis

Mesh:

Substances:

Year:  2016        PMID: 27465156     DOI: 10.1007/s00277-016-2757-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Inhibitory effect of AQP1 silencing on adhesion and angiogenesis in ectopic endometrial cells of mice with endometriosis through activating the Wnt signaling pathway.

Authors:  Chang Shu; Yang Shu; Yongmei Gao; Hui Chi; Jun Han
Journal:  Cell Cycle       Date:  2019-07-15       Impact factor: 4.534

2.  Cryohemolysis, erythrocyte osmotic fragility, and supplementary hematimetric indices in the diagnosis of hereditary spherocytosis.

Authors:  Ledesma Achem Miryam Emilse; Haro Cecilia; Terán Magdalena María; Mónaco María Eugenia; Issé Blanca Alicia; Sandra Stella Lazarte
Journal:  Blood Res       Date:  2018-03-27

Review 3.  The Evolution of Cholesterol-Rich Membrane in Oxygen Adaption: The Respiratory System as a Model.

Authors:  Juan Pablo Zuniga-Hertz; Hemal H Patel
Journal:  Front Physiol       Date:  2019-10-29       Impact factor: 4.566

4.  AQP0 is a novel surface marker for deciphering abnormal erythropoiesis.

Authors:  Tso-Fu Wang; Guan-Ling Lin; Sung-Chao Chu; Chang-Chin Chen; Yu-Shan Liou; Hsin-Hou Chang; Der-Shan Sun
Journal:  Stem Cell Res Ther       Date:  2021-05-06       Impact factor: 6.832

5.  Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness.

Authors:  Nareg H Roubinian; Sarah E Reese; Hannah Qiao; Colleen Plimier; Fang Fang; Grier P Page; Ritchard G Cable; Brian Custer; Mark T Gladwin; Ruchika Goel; Bob Harris; Jeanne E Hendrickson; Tamir Kanias; Steve Kleinman; Alan E Mast; Steven R Sloan; Bryan R Spencer; Steven L Spitalnik; Michael P Busch; Eldad A Hod
Journal:  JCI Insight       Date:  2022-01-11

Review 6.  Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles.

Authors:  M Geiger; E Hayter; R S Martin; D Spence
Journal:  J Transl Autoimmun       Date:  2022-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.